skip to main content

Chemistry, part 3

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > c-glycosyl compound > 2-[(2r,5s,6s)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > c-glycosyl compound > 2-[(2r,5s,6s)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > c-glycosyl compound > 2-[(2r,5s,6s)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > c-glycosyl compound > 2-[(2r,5s,6s)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > c-glycosyl compound > 2-[(2r,5s,6s)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-n-[3-(4-morpholinyl)propyl]acetamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > c-glycosyl compound > 2-[(2r,5s,6s)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-n-[3-(4-morpholinyl)propyl]acetamide

Preferred term

2-[(2r,5s,6s)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-n-[3-(4-morpholinyl)propyl]acetamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C23H34N4O7

inchi

  • InChI=1S/C23H34N4O7/c28-14-21-18(26-23(30)25-16-2-5-19-20(12-16)33-15-32-19)4-3-17(34-21)13-22(29)24-6-1-7-27-8-10-31-11-9-27/h2,5,12,17-18,21,28H,1,3-4,6-11,13-15H2,(H,24,29)(H2,25,26,30)/t17-,18+,21-/m1/s1

inchikey

  • WGFFUWNETOGMCB-LVCYWYKZSA-N

mass

  • 478.540

monoisotopicmass

  • 478.24275

smiles

  • C1C[C@@H]([C@H](O[C@H]1CC(=O)NCCCN2CCOCC2)CO)NC(=O)NC3=CC4=C(C=C3)OCO4

subset

  • 2_STAR

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:102003

Download this concept:

RDF/XML TURTLE JSON-LD